Meitheal Pharmaceuticals, Inc. Email Format
Pharmaceutical ManufacturingIllinois, United States51-200 Employees
Meitheal Pharmaceuticals, Inc. is a privately held manufacturer focused on developing and supplying generic injectable medicines. Founded in 2017 and based in the Chicago area, the company emphasizes an established management team and a growth-oriented approach supported by global partnerships to ensure a reliable, high-quality, affordable supply of injectables for US healthcare providers. It operates in the pharmaceutical manufacturing sector with a focus on generics and seeks to meet demand for safe, accessible injectable therapies through international collaboration. The company serves US healthcare providers seeking dependable injectable options within the generic space. A notable recent development is the April 2026 introduction of propofol sedation vials in three single-dose sizes for ICU and surgical use, designed to reduce waste and dosing errors.